Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19)
- PMID: 32386448
- PMCID: PMC7272891
- DOI: 10.1111/jdv.16613
Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19)
Figures


References
-
- Costanzo M, De Giglio MAR, Roviello GN. SARS‐CoV‐2: recent reports on antiviral therapies based on lopinavir/ritonavir, darunavir/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus. Curr Med Chem 2020; 27. 10.2174/0929867327666200416131117. [Epub ahead of print]. - DOI - PubMed
-
- http://www.simit.org/medias/1569‐covid19‐vademecum‐13‐03‐202.pdf. (last accessed: 17 April 2020).
-
- Sidoroff A, Dunant A, Viboud C et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)‐results of a multinational case‐control study (EuroSCAR). Br J Dermatol 2007; 157: 989–996. - PubMed
-
- Ghosn J, Duvivier C, Tubiana R, Katlama C, Caumes E. Acute generalized exanthematous pustulosis induced by HIV postexposure prophylaxis with lopinavir‐ritonavir. Clin Infect Dis 2005; 41: 1360–1361. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources